٢٢ ﻣﻦ١ ﺻڡﺤﺔ ﮲ The cephalosporins are β -lactam antibiotics isolated from Cephalosporium spp. or prepared semisynthetically. Most of the antibiotics introduced since 1965 have been semisynthetic cephalosporins. In the preparation of semisynthetic cephalosporins, the following improvements are sought: (a) increased acid stability. (b) improved pharmacokinetic properties, particularly better oral absorption. (c) broadened antimicrobial spectrum. (d) increased activity against resistant microorganisms (as a result of resistance to enzymatic destruction), improved penetration, increased receptor affinity, etc . (e) decreased allergenicity. (f) increased tolerance after parenteral administration.
٢٢ ﻣﻦ٢ ﺻڡﺤﺔ ﮲ Chemical experience Cephalosporins Degradation various hydrolytic degradation reactions whose specific nature depends on the individual structure. Among 7-acylaminocephalosporanic acid derivatives, the 3-acetoxylmethyl group is the most reactive site. In addition to its reactivity to nucleophilic displacement reactions, the acetoxyl function of this group readily undergoes solvolysis in strongly acidic solutions to form the desacetylcephalosporin derivatives. The latter lactonize to form the desacetylcephalosporin lactones, which are virtually inactive. The 7-acylamino group of some cephalosporins can also be hydrolyzed under enzymatic (acylases) and, possibly, nonenzymatic conditions to give 7- ACA (or 7-ADCA) derivatives. 7-ACA also lactonizes under acidic conditions. The reactive functionality common to all cephalosporins is the β-lactam. Hydrolysis of the β -lactam of cephalosporins is believed to give initially cephalosporoic acids (in which the R group is stable, [e.g., R H or S heterocycle]) or possibly anhydrodesacetylcephalosporoic acids (7-ADCA, for the 7-acylaminocephalosporanic acids). It has not been possible to isolate either of these initial hydrolysis products in aqueous systems. Apparently, both types of cephalosporanic acid undergo fragmentation reactions that have not been characterized fully.
٢٢ ﻣﻦ٣ ﺻڡﺤﺔ ﮲ Studies of the in vivo metabolism of orally administered cephalosporins, however, have demonstrated arylacetylglycines and arylacetamidoethanols, which are believed to be formed from the corresponding arylacetylaminoacetaldehydes by metabolic oxidation and reduction, respectively.
Chemical and enzymatic degradation of cephalosporins.
٢٢ ﻣﻦ٤ ﺻڡﺤﺔ ﮲ Oral Cephalosporins The oral activity conferred by increased acid stability of the lactam ring, resulting from the presence of a protonated amino group on the 7-acylamino portion of the molecule. Carrier mediated transport of these dipeptide-like, zwitterionic cephalosporins is also an important factor in their excellent oral activity. It is analogous to that of the aminobenzylpenicillins (e.g., ampicillin). Also important for high acid stability (and, therefore, good oral activity) of the cephalosporins is the absence of the leaving group at the 3-position. Oral activity can also be conferred in certain cephalosporins by esterification of the 3-carboxylic acid group to form acid-stable, lipophilic esters that undergo hydrolysis in the plasma., e.g Cefuroxime axetil and cefpodoxime proxetil . Parenteral Cephalosporins Hydrolysis of the ester function, catalyzed by hepatic and renal esterases, is responsible for some in vivo inactivation of parenteral cephalosporins containing a 3-acetoxymethyl substituent (e.g., cephalothin, cephapirin, and cefotaxime). The extent of such inactivation (20%–35%) is not large enough to seriously compromise the in vivo effectiveness of acetoxyl cephalosporins. Parenteral cephalosporins lacking a hydrolyzable group at the 3-position are not subject to hydrolysis by esterases.
٢٢ ﻣﻦ٦ ﺻڡﺤﺔ ﮲ Spectrum of Activity The cephalosporins are considered broad- spectrum antibiotics with patterns of antibacterial effectiveness comparable to that of ampicillin. Several significant differences exist, however. Cephalosporins are much more resistant to inactivation by β-lactamases, particularly those produced by Gram-positive bacteria, than is ampicillin. Ampicillin, however, is generally more active against non β-lactamase-producing strains of Gram-positive and Gram-negative bacteria
٢٢ ﻣﻦ٧ ﺻڡﺤﺔ ﮲ β -Lactamase Resistance The susceptibility of cephalosporins to various lactamases varies considerably with the source and properties of these enzymes. Cephalosporins are significantly less sensitive than β-lactamase–resistant penicillins to hydrolysis by the enzymes from S. aureus and Bacillus subtilis. The “penicillinase” resistance of cephalosporins appears to be a property of the bicyclic cephem ring rather than of the acyl group. Despite natural resistance to staphylococcal β -lactamase, the different cephalosporins exhibit considerable variation in rates of hydrolysis by the enzyme. Thus, of several cephalosporins tested in vitro, cephalothin and cefoxitin are the most resistant, and cephaloridine and cefazolin are the least resistant. The same acyl functionalities that impart β -lactamase resistance in the penicillins unfortunately render cephalosporins inactive against S. aureus and other Gram-positive bacteria. The introduction of polar substituents in the aminoacyl moiety of cephalosporins appears to confer stability to some β-lactamases. Thus, cefamandole and cefonicid, which contain an α-hydroxyphenylacetyl (or mandoyl) group, and ceforanide, which has an o-aminophenyl acetyl group, are resistant to a few β-lactamases.
٢٢ ﻣﻦ٨ ﺻڡﺤﺔ ﮲ Steric factors also may be important because cefoperazone, an acylureidocephalosporin that contains the same 4-ethyl-2,3-dioxo-1-piperazinylcarbonyl group present in piperacillin, is resistant to many β-lactamases. Oddly enough, piperacillin is hydrolyzed by most of these enzymes. Two structural features confer broadly based resistance to β- lactamases among the cephalosporins: (a) An alkox-imino function in the aminoacyl group. (b) A methoxyl substituent at the 7-position of the cephem nucleus having α- stereochemistry. The structures of several β-lactamase-resistant cephalosporins, including cefuroxime, cefotaxime, ceftizoxime, and ceftriaxone, feature a methoximino acyl group. β-Lactamase resistance is enhanced modestly if the oximino substituent also features a polar function, as in ceftazidime, which has a 2-methylpropionic acid substituent on the oximino group. Both steric and electronic properties of the alkoximino group may contribute to the β- lactamase resistance conferred by this functionality since syn-isomers are more potent than anti-isomers.
٢٢ ﻣﻦ٩ ﺻڡﺤﺔ ﮲ Antipseudomonal Cephalosporins Species of Pseudomonas, especially P. aeruginosa, represent a special public health problem because of their ubiquity in the environment and their propensity to develop resistance to antibiotics, including the β-lactams. The primary mechanisms of β-lactam resistance appear to involve destruction of the antibiotics by β-lactamases and/or interference with their penetration through the cell envelope. Apparently, not all β-lactamase-resistant cephalosporins penetrate the cell envelope of P. aeruginosa, as only cefoperazone, moxalactam, cefotaxime, ceftizoxime, ceftriaxone, and ceftazidime have useful antipseudomonal activity. Two cephalosporins, moxalactam and cefoperazone, contain the same polar functionalities (e.g., carboxy and N-acylureido) that facilitate penetration into Pseudomonas spp. by the penicillins (see carbenicillin, ticarcillin, and piperacillin). Unfortunately, strains of P. aeruginosa resistant to cefoperazone and cefotaxime have been found in clinical isolates.
٢٢ ﻣﻦ١٠ ﺻڡﺤﺔ ﮲ Adverse Reactions and Drug Interactions Cephalosporins containing an N-methyl-5-thiotetrazole (MTT) moiety at the 3-position (e.g., cefamandole, cefotetan,cefmetazole, moxalactam, and cefoperazone) have been implicated in a higher incidence of hypoprothrombinemia than cephalosporins lacking the MTT group. The MTT group has also been implicated in the intolerance to alcohol associated with certain injectable cephalosporins: cefamandole, cefotetan, cefmetazole, and cefoperazone. Thus, disulfiram-like reactions, attributed to the accumulation of acetaldehyde and resulting from the inhibition of aldehyde dehydrogenase–catalyzed oxidation of ethanol by MTT-containing cephalosporins, may occur in patients who have consumed alcohol before, during, or shortly after the course of therapy.
٢٢ ﻣﻦ١١ ﺻڡﺤﺔ ﮲ Classification Cephalosporins are divided into first-, second-, third-, and fourth-generation agents, based roughly on their time of discovery and their antimicrobial properties. In general, progression from first to fourth generation is associated with a broadening of the Gram-negative antibacterial spectrum, some reduction in activity against Gram-positive organisms, and enhanced resistance to β - lactamases. Individual cephalosporins differ in their pharmacokinetic properties, especially plasma protein binding and half-life, but the structural differences are not obvious.
orally active, semisynthetic cephalosporin. The oral inactivation of cephalosporins has been attributed to two causes: instability of the β -lactam ring to acid hydrolysis and solvolysis or microbial transformation of the 3-methylacetoxy group. The α-amino group of cephalexin renders it acid stable, and reduction of the 3- acetoxymethyl to a methyl group circumvents reaction at that site. It is freely soluble in water, resistant to acid, and absorbed well orally. Food does not interfere with its absorption. Because of minimal protein binding and nearly exclusive renal excretion, cephalexin is recommended particularly for the treatment of urinary tract infections. It is also sometimes used for upper respiratory tract infections. Its spectrum of activity is very similar to those of cephalothin and cephaloridine. Cephalexin is somewhat less potent than these two agents after parenteral administration and, therefore, is inferior to them for the treatment of serious systemic infections.
It is the first of a series of α-methoximinoacyl– substituted cephalosporins that constitute
most of the second -generation agents available for clinical use. A syn alkoximino substituent is associated with β -lactamase stability in these cephalosporins. Cefuroxime is classified as a second generation cephalosporin because its spectrum of antibacterial activity more closely resembles that of cefamandole. It is, however, active against β - lactamase–producing strains that are resistant to cefamandole, such as E. coli, K. pneumoniae, N. gonorrhoeae, and H. influenzae. Other important Gram-negative pathogens, such as Serratia, indole-positive Proteus spp., P. aeruginosa, and B. fragilis, are resistant. Cefuroxime is distributed throughout the body. It penetrates inflamed meninges in high enough concentrations to be effective in meningitis caused by susceptible organisms. Three-times-daily dosing is required to maintain effective plasma levels for most sensitive organisms, such as Neisseria meningitidis, Streptococcus pneumoniae, and H. influenzae. It has a plasma half-life of 1.4 hours.
Cefotaxime was the first third-generation cephalosporin to be introduced. It possesses
excellent broad-spectrum activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. It is more active than moxalactam against Gram-positive organisms. Many β-lactamase-producing bacterial strains are sensitive to cefotaxime. The syn-isomer of cefotaxime is significantly more active than the anti-isomer against β-lactamase- producing bacteria. This potency difference is, in part, because of greater resistance of the syn-isomer to the action of β-lactamases. The higher affinity of the syn-isomer for PBPs, however, may also be a factor. Cefotaxime is metabolized in part to the less active desacetyl metabolite. Approximately 20% of the metabolite and 25% of the parent drug are excreted in the urine. Solutions of cefotaxime sodium should be used within 24 hours. If stored, they should be refrigerated. Refrigerated solutions maintain potency up to 10 days.
Ceftriaxone is a β-lactamase-resistant cephalosporin with an extremely long serum half-
life. Once-daily dosing suffices for most indications. Two factors contribute to the prolonged duration of action of ceftriaxone: high protein binding in the plasma and slow urinary excretion. Ceftriaxone is excreted in both the bile and the urine. Despite its comparatively low volume of distribution, it reaches the cerebrospinal fluid in concentrations that are effective in meningitis. Nonlinear pharmacokinetics are observed. Ceftriaxone contains a highly acidic heterocyclic system on the 3-thiomethyl group . This unusual dioxotriazine ring system is believed to confer the unique pharmacokinetic properties of this agent. Ceftriaxone exhibits excellent broad-spectrum antibacterial activity against both Gram- positive and Gram-negative organisms. Solutions of ceftriaxone sodium should be used within 24 hours. They may be stored up to 10 days if refrigerated.
generation cephalosporin that is noted for its antipseudomonal activity. It is active against some strains of P. aeruginosa that are resistant to cefoperazone and ceftriaxone. Ceftazidime is also highly effective against β-lactamase-producing strains of the Enterobacteriaceae family. The structure of
٢٢ ﻣﻦ١٧ ﺻڡﺤﺔ ﮲ NEWER CEPHALOSPORINS Cephalosporins currently undergoing clinical trials or recently being marketed in the United States fall into two categories: (a) orally active β -lactamase–resistant cephalosporins (b) parenteral β -lactamase–resistant antipseudomonal cephalosporins. The status of some of these compounds awaits more extensive clinical evaluation. Nonetheless, it appears that any advances they represent will be relatively modest.
Cefpirome
Cefpirome (Cefrom) is a newer parenteral, β -lactamase– resistant cephalosporin with a
quaternary ammonium group at the 3-position of the cephem nucleus. Because its potency against Gram-positive and Gram-negative bacteria rivals that of the first- generation and third-generation cephalosporins, respectively, cefpirome is being touted as the first fourth generation cephalosporin. Its broad spectrum includes methicillin-sensitive staphylococci, penicillin-resistant pneumococci, and β -lactamase–producing strains of E. coli, Enterobacter, Citrobacter, and Serratia spp. Its efficacy against P. aeruginosa is comparable with that of ceftazidime. Cefpirome is excreted largely unchanged in the urine with a half-life of 2 hours.
٢٢ ﻣﻦ١٨ ﺻڡﺤﺔ ﮲ Future Developments in Cephalosporin Design Recent research efforts in the cephalosporin field have focused primarily on two desired antibiotic properties: (a) increased permeability into Gram-negative bacilli, leading to enhanced efficacy against permeability-resistant strains of Enterobacteriaceae and P. aeruginosa. (b) increased affinity for altered PBPs, in particular the PBP 2a (or PBP 2') of MRSA. The observation that certain catechol-substituted cephalosporins exhibit marked broad- spectrum antibacterial activity led to the discovery that such compounds and other analogs capable of chelating iron could mimic natural siderophores (iron-chelating peptides) and thus be actively transported into bacterial cells via the tonB-dependent iron-transport system. This provides a means of attacking bacterial strains that resist cellular penetration of cephalosporins.
٢٢ ﻣﻦ١٩ ﺻڡﺤﺔ ﮲ MONOBACTAMS The development of useful monobactam antibiotics began with the independent isolation of sulfazecin and other monocyclic β -lactam antibiotics from saprophytic soil bacteria in Japan and the United States. Sulfazecin was found to be weakly active as an antibacterial agent but highly resistant to β -lactamases. Extensive SAR studies eventually led to the development of aztreonam, which has useful properties as an antibacterial agent. Early work established that the 3-methoxy group, which was in part responsible for β -lactamase stability in the series, contributed to the low antibacterial potency and poor chemical stability of these antibiotics.
A 4-methyl group, however, increases stability to β -lactamases and activity against
Gram-negative bacteria at the same time. Unfortunately, potency against Gram-positive bacteria decreases. 4,4-Gem-dimethyl substitution slightly decreases antibacterial potency after oral administration,
٢٢ ﻣﻦ٢٠ ﺻڡﺤﺔ ﮲ Products Aztreonam Disodium Aztreonam (Azactam) is a monobactam prepared by total synthesis. It binds with high affinity to PBP 3 in Gram-negative bacteria only. It is inactive against Gram-positive bacteria and anaerobes. β -Lactamase resistance is like that of ceftazidime, which has the same isobutyric acid oximinoacyl group. Aztreonam is particularly active against aerobic Gram-negative bacilli, including E. coli, K. pneumoniae, Klebsiella oxytoca, P. mirabilis, S. marcescens, Citrobacter spp., and P. aeruginosa. It is used to treat urinary and lower respiratory tract infections, intra-abdominal infections, and gynecologicalinfections, as well as septicemias caused by these organisms. It is not active against Gram-positive bacteria, anaerobic bacteria, or other species of Pseudomonas. Urinary excretion is about 70% of the administered dose. Some is excreted through the bile. Serum half-life is 1.7 hours, which allows aztreonam to be administered 2 or 3 times daily, depending on the severity of the infection. Less than 1% of an orally administered dose of aztreonam is absorbed, prompting the suggestion that this β -lactam could be used to treat intestinal infections. The disodium salt of aztreonam is very soluble in water. Solutions for parenteral administration containing 2% or less are stable for 48 hours at room temperature..
Tigemonam is a newer monobactam that is orally active. It is highly resistant to β -
lactamases. The antibacterial spectrum of activity resembles that of aztreonam. It is very active against the Enterobacteriaceae, including E. coli, Klebsiella, Proteus, Citrobacter, Serratia, and Enterobacter spp. It also exhibits good potency against H. influenzae and N. gonorrhoeae. Tigemonam is not particularly active against Gram positive or anaerobic bacteria and is inactive against P. aeruginosa. In contrast to the poor oral bioavailability of aztreonam, the oral absorption of tigemonam is excellent. It could become a valuable agent for the oral treatment of urinary tract infections and other non–life-threatening infections caused by β - lactamase–producing Gram-negative bacteria.